Development and verification of a novel immunogenic cell death‐related signature for predicting the prognosis and immune infiltration in triple‐negative breast cancer

Documenti analoghi

• Cyclin‐dependent kinase inhibitors enhance programmed cell death protein 1 immune checkpoint blockade efficacy in triple‐negative breast cancer by affecting the immune microenvironment
  di: Jiayi Wu, et al.
  Pubblicazione: (2024)
• Mitochondrial dynamics as a novel treatment strategy for triple‐negative breast cancer
  di: Yuechen Wang, et al.
  Pubblicazione: (2024)
• Periostin is associated with prognosis and immune cell infiltration in pancreatic adenocarcinoma based on integrated bioinformatics analysis
  di: Yijun Chen, et al.
  Pubblicazione: (2024)
• Guideline concordance in triple‐negative breast cancer: What does it measure?
  di: Jennifer L. Caswell‐Jin, et al.
  Pubblicazione: (2026)
• Implication of IZUMO2 in the cell‐in‐cell phenomenon: A potential therapeutic target for triple‐negative breast cancer
  di: Toshiya Higashi, et al.
  Pubblicazione: (2024)